Please select the option that best describes you:
Topics:
Ophthalmology • Neuro-Ophthalmology • Endocrinology • Thyroid Disorders • Oculoplastic Surgery
Should teprotumumab be used in patients with active, moderate Graves thyroid eye disease in the absence of proptosis?
Answer from: at Community Practice
Proptosis is not the only manifestation of TED. Diplopia and lid retraction are a big deal, and Tepezza can help with this.
Sign in or Register to read more